Fidelity International
ARRY

Fidelity International’s Array Biopharma Inc ARRY Stock Holding History

Fidelity International’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,865,000
Closed -$133M – 1006
2019
Q2 		$133M Buy
+2,865,000
New +$80.4M 0.2% 136

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

Fidelity International's ARRY Position: Q3 2019 in Review

Fidelity International sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,865,000 shares — an estimated $133M sold.

Fidelity International first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $133M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Fidelity International reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Fidelity International sold 2,865,000 Array Biopharma Inc shares in Q3 2019, an estimated $133M.
  • Fidelity International first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
  • Fidelity International's Array Biopharma Inc position peaked at $133M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Fidelity International's 13F filing for Q3 2019, filed 13 Nov 2019.